Correlation Between ABO Blood Group System and COVID-19 Severity in Erbil
DOI:
https://doi.org/10.23918/eajse.v9i2p12Keywords:
ABO Blood Group, COVID-19, Clinical Trials, KurdistanAbstract
The incidence of SARS-CoV-2, or severe acute respiratory syndrome, can differ considerably, implying that personal characteristics affect how a disease grows. The aims to demonstrate a relationship between Kurdish patients' ABO blood groups and the severity of COVID-19. The study evaluated 300 COVID-19 patients who visited Rzgary Hospital and Zheen International Hospital in Erbil between April 2020 and December 2020, and collected data on age, gender, disease severity, and ABO blood groups. The chi-square statistic applied to examine the frequency and correlation of blood groups, and It was determined the odds ratios (ORs) and 95% confidence intervals (CIs). for severe and non-severe cases. The study included 186 males and 114 females aged 10 to 87 years old, and the blood groups frequencies A, O, B, and AB were 33.7%, 32.3%, 21.7%, and 12.3%, respectively. The study found no significant difference in COVID-19 severity for ABO blood groups A, O, B, and AB. Although there was a minor to moderate correlation between ABO blood group and COVID-19 severity, the chi-square analysis found that it was not statistically significant (p-value = 0.304). The odds ratios and 95% CIs for A, O, B, and AB blood types were 0.560 (0.256-1.224), 0.520 (0.236-1.114), 0.934 (0.436-2.00), and 0.768 (0.337-1.749), respectively.
References
[1] Merza MY, Hwaiz RA, Hamad BK, Mohammad KA, Hama HA, Karim AY. Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq. Plos one. 2021; 16(4): e0250330. https://doi.org/10.1371/journal.pone.0250330
[2] Nalbant A, Aydın A, Yaylacı S, Kaya T, Wermeulen CL, Cinemre H. Association of ABO blood group and age with COVID-19 positive test. Revista da Associação Médica Brasileira. 2021; 67: 46-50. https://doi.org/10.1590/1806-9282.67.Suppl1.20200703
[3] Storry J, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology. 2009; 25(2): 48. https://doi.org/10.21307/immunohematology-2019-231
[4] Hama HA, Hamatahir SK, Sirwan Y. Distribution of ABO Blood Groups in Acute Leukemia Patients in Sulaymaniyah, Kurdistan Region of Iraq. Applied Biological Research. 2022; 24(2): 119-25. http://dx.doi.org/10.5958/0974-4517.2022.00015.5
[5] Wu B-B, Gu D-Z, Yu J-N, Yang J, Shen W-Q. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis. Infection, Genetics and Evolution. 2020; 84: 104485. https://doi.org/10.1016/j.meegid.2020.104485
[6] Ad’hiah AH, Allami RH, Mohsin RH, Abdullah MH, AL-Sa’ady AJ, Alsudani MY. Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients. Egyptian Journal of Medical Human Genetics. 2020; 21(1): 1-6.
[7] El-Shitany NA, El-Hamamsy M, Alahmadi AA, Eid BG, Neamatallah T, Almukadi HS, et al. The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community. International Journal of Environmental Research and Public Health. 2021; 18(1): 276. https://doi.org/10.3390/ijerph18010276
[8] Groot HE, Villegas Sierra LE, Said MA, Lipsic E, Karper JC, van der Harst P. Genetically determined ABO blood group and its associations with health and disease. Arteriosclerosis, thrombosis, and vascular biology. 2020; 40(3): 830-8. https://doi.org/10.1161/ATVBAHA.119.313658
[9] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020; 395(10223): 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
[10] Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483): 1260-3. https://doi.org/10.1126/science.abb2507
[11] Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population‐based cross‐sectional study. Journal of viral hepatitis. 2018; 25(4): 401-11. https://doi.org/10.1111/jvh.12829
[12] Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International journal of oral science. 2020; 12(1): 1-5. https://doi.org/10.1038/s41368-020-0074-x
[13] Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, et al. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science. 2020; 370(6515): 426-31. https://doi.org/10.1126/science.abd9909
[14] Guillon P, Clément M, Sébille V, Rivain J-G, Chou C-F, Ruvoën-Clouet N, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008; 18(12): 1085-93. https://doi.org/10.1093/glycob/cwn093
Downloads
Published
Issue
Section
License
License
Eurasian J. Sci. Eng is distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY-4.0) https://creativecommons.org/licenses/by/4.0/
